"Peak" was identified as China's well-known trademark
Release time:
2020-07-31
News Recently, the Trademark Office of the State Administration for Industry and Commerce issued a document that the "Peak" trademark held by Peak Pharmaceutical Company was recognized as a well-known trademark. The main contents of the document "Reply of the Trademark Office of the State Administration for Industry and Commerce on the Identification of" Jianfeng "Trademark as a Well-known Trademark" (Shang Biao Chi Zi [
] 121 ) are as follows: according to the relevant provisions of the Trademark Law, the Regulations on the Implementation of the Trademark Law and the Provisions on the Identification and Protection of Well-known Trademarks, after examination and research, it is recognized that the registered trademark "Jianfeng" used by Zhejiang Jianfeng Pharmaceutical Co., Ltd. on human drugs, chemical bulk drugs and chemical pharmaceutical preparations in category 5 of the International Classification of Goods and Services for Trademark Registration is a well-known trademark. The identification of the well-known trademark has effectively enhanced the brand value of the company, helped to improve the popularity of the company's products, and further strengthened the protection of the "peak" trademark. (Zhou Hengbin)
"Well-known Trade Mark
1883 . According to international and domestic intellectual property laws and regulations, the well-known trademark system is created to fully protect the legitimate rights and interests of well-known trademark owners. Its purpose is to reasonably protect the relevant trademark ownership, maintain fair competition, and stop infringement of others' trademark exclusive rights. behavior. China joined the Convention in 1984 , according to the provisions of the Convention to give special legal protection to well-known trademarks, has become an important part of China's trademark legal work. China Famous Trade Mark (
) refers to a trademark type that is recognized as a "well-known trademark" by the Trademark Office of the State Administration for Industry and Commerce in accordance with legal procedures according to the application of an enterprise. According to the "Regulations on the Recognition and Protection of Well-known Trademarks" promulgated by the State Administration for Industry and Commerce, its meaning can be summarized as: a trademark that is widely known to the relevant public and enjoys a high reputation in China. The relevant public includes consumers related to certain types of goods or services marked by the use of trademarks, other operators who produce the aforementioned goods or provide services, and sellers and related personnel involved in the distribution channels. Well-known trademarks not only have the distinction of general trademarks, but also have strong competitiveness, high visibility, wide range of influence, have been known and trusted by consumers and operators, and have related commercial value. These characteristics make it often the object of violation. Therefore, China's well-known trademarks are protected better than ordinary registered trademarks in accordance with the law, that is, ordinary trademarks can only be protected by law in the category of goods or services that have been approved for registration, and enjoy the right to exclusive use of trademarks; while well-known trademarks have different degrees of cross-category protection due to their originality and distinctiveness. When different or dissimilar goods are applied for registration or use, they will not be registered and prohibited, given a relatively wide range of exclusive rights, the company name and website domain name of well-known trademark holding enterprises will be protected by special laws different from ordinary trademarks. Therefore, well-known trademarks can not only fight against other people's malicious rush to register, increase the gold content of the brand, appreciate the intangible assets of the enterprise, expand the popularity of the enterprise, and enhance the market competitiveness of the enterprise; it can also increase the recognition of the government and the public to the enterprise, and increase the intensity of infringement and anti-counterfeiting. At the same time, it will get more preferential treatment and support in other fields such as investment and credit; in the event of preemptive registration or infringement abroad (in a member country of the Paris Convention), the enterprise may also file an application for revocation or protection with the relevant competent authority.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page